Nucleic acids are one of several macromolecules found in the body in addition to fats, proteins, and carbohydrates. A nucleic acid is a polymer composed of four nucleotides linked together in a long chain known as polynucleotide. A nucleic acid consists of DNA, RNA, and protein. The extraction and purging of nucleic acids are regularly utilized strategies to isolate genetic material from tissues, microscopic organisms, plants, and infections for imperative, explanatory, indicative, and preparative downstream procedures. Among these techniques, plasmid DNA extraction was the first to be recorded to have utilized the tedious alkaline extraction protocol. Generally, successful refining of nucleic acids involves four important steps viz. effective disruption of cells or tissues, denaturation of nucleoprotein complexes, inactivation of nucleases (for example, RNase for RNA extraction and DNase for DNA extraction), and decontamination. The recent point-of-care diagnostics (POC-Dx) is a new approach aimed at replacement of sophisticated analytical machinery with micro-analytical systems, and able to be used near the patient, at the point of care or point of need.
Based on chemical, the nucleic acid extraction reagents market has been segmented into proteinase K, NaCl, CTAB/NaCl solution, chloroform/isoamyl alcohol 24:1, phenol/chloroform/isoamyl alcohol 25:24:1, isopropanol, and ethanol. Ethanol and phenol segments are expanding at a high rate, as the two reagents are easily available, price-compatible, and highly effective. Based on end-user, the nucleic acid extraction reagents market can be classified into academic research institutes, hospitals & diagnostic centers, pharmaceutical & biotechnology companies, contract research organizations (CROs), and others (such as food testing and forensic laboratories). The academic research institutes segment holds a leading share of the global market, while the hospitals & diagnostic centers segment is likely to expand at the maximum growth rate during the forecast period. This growth is attributable to the increasing use of nucleic acid tests in molecular diagnostics. The importance of pure nucleic acid for applications in industries such as pharmaceutical and biotechnological has filled its request in the examination and life science markets. The confinement of nucleic corrosive in the pure shape is required for medicate disclosure, sub-atomic diagnostics, and genotypic applications. The mechanical developments and progressions; and government activities in type of subsidizing for investigate ventures are the elements driving this market. Besides, the expanding utilization of nucleic corrosive based tests in conclusion is relied upon to drive this market in coming future. However, expending market consolidation and low penetration of automated nucleic acid isolation and sanitization techniques in emerging economies are the major factors hindering the growth of this market.
Geographically, the global nucleic acid extraction reagents market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe cumulatively held a major share of the global market, due to rapid economic development and increase in health care expenditure in these regions. However, countries in Asia Pacific such as India, China, and Japan offer immense growth opportunities for the market, due to increasing R&D expenditure and technological advancements in these countries. In Middle East & Africa countries the development of the healthcare project and economy help to increase the market of the nucleic acid extraction reagent.
Key players operating in the global market for nucleic acid extraction reagents are Agilent Technologies Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche AG, General Electric Company, Qiagen N.V., Sigma-Aldrich Co. LLC, Takara Bio, Inc., and Thermo Fisher Scientific, Inc.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.